GSK Applies For Approval Of World’s First Malaria Vaccine
Reuters: GSK seeks approval for world’s first malaria vaccine
“GlaxoSmithKline (GSK.L) said on Thursday it is applying for regulatory approval for the world’s first vaccine against malaria, designed for children in Africa…” (Kelland, 7/24).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.